Almassabi Rehab F, Mir Rashid, Javid Jamsheed, AbuDuhier Faisel M, Almotairi Reema, Alhelali Marwan H, Algehainy Naseh, Alsaedi Basim S O, Albalawi Salem Owaid, Elfaki Imadeldin
Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.
Department of Medical Lab Technology, Prince Fahad Bin Sultan Chair for Biomedical Research, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia.
Life (Basel). 2023 Oct 31;13(11):2142. doi: 10.3390/life13112142.
Coronary artery disease (CAD) is the leading cause of death and hospitalization worldwide and represents a problem for public health systems everywhere. In Saudi Arabia, the prevalence of CAD is estimated to be 5.5%. Risk factors for CAD include older age, male gender, obesity, high blood pressure, smoking, diabetes, hyperlipidemia, and genetic factors. Reducing the risk factors in susceptible individuals will decrease the prevalence of CAD. Genome wide association studies have helped to reveal the association of many loci with diseases like CAD. In this study, we examined the link between single nucleotide variations (SNVs) of TNF-α-rs1800629 G>A, CYP2C1917 (rs12248560) C>T, and miR-423 rs6505162 C>A and the expression of TNF-α with CAD. We used the mutation specific PCR, ARMS-PCR, and ELISA. The results showed that the A allele of the TNF-α rs1800629 G>A SNP is linked to CAD with odd ratio (OR) (95% CI) = 2.10, -value = 0.0013. The T allele of the (rs12248560) C>T is linked to CAD with OR (95% CI) = 2.02, -value = 0.003. In addition, the A allele of the miR-423 rs6505162 C>A SNV is linked to CAD with OR (95% CI) = 1.49, -value = 0.036. The ELISA results indicated that the TNF-α serum levels are significantly increased in CAD patients compared to healthy controls. We conclude the TNF-α rs1800629 G>A, CYP2C1917, and miR-423 rs6505162 C>A are potential genetic loci for CAD in the Saudi population. These findings require further verification in future studies. After being verified, our results might be utilized in genetic testing to identify individuals that are susceptible to CAD and, therefore, for whom reducing modifiable risk factors (e.g., poor diet, diabetes, obesity, and smoking) would result in prevention or delay of CAD.
冠状动脉疾病(CAD)是全球范围内导致死亡和住院的主要原因,对各地的公共卫生系统而言都是一个问题。在沙特阿拉伯,CAD的患病率估计为5.5%。CAD的风险因素包括年龄较大、男性、肥胖、高血压、吸烟、糖尿病、高脂血症和遗传因素。降低易感个体的风险因素将降低CAD的患病率。全基因组关联研究有助于揭示许多基因座与CAD等疾病的关联。在本研究中,我们检测了TNF-α-rs1800629 G>A、CYP2C1917(rs12248560)C>T和miR-423 rs6505162 C>A的单核苷酸变异(SNV)与CAD患者中TNF-α表达之间的联系。我们使用了突变特异性PCR、ARMS-PCR和ELISA。结果显示,TNF-α rs1800629 G>A SNP的A等位基因与CAD相关,比值比(OR)(95%置信区间)=2.10,P值=0.0013。CYP2C1917(rs12248560)C>T的T等位基因与CAD相关,OR(95%置信区间)=2.02,P值=0.003。此外,miR-423 rs6505162 C>A SNV的A等位基因与CAD相关,OR(95%置信区间)=1.49,P值=0.036。ELISA结果表明,与健康对照相比,CAD患者的TNF-α血清水平显著升高。我们得出结论,TNF-α rs1800629 G>A、CYP2C19*17和miR-423 rs6505162 C>A是沙特人群中CAD的潜在基因座。这些发现需要在未来的研究中进一步验证。经过验证后,我们的结果可能会用于基因检测,以识别易患CAD的个体,因此,对于这些个体而言,降低可改变的风险因素(如不良饮食、糖尿病、肥胖和吸烟)可能会预防或延缓CAD的发生。